Cargando…
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
SIMPLE SUMMARY: The identification of clinical and tumor factors to identify patients who most benefit from oncological treatments is a crucial clinical unmet need. We studied differences in the tumor microenvironment assessed using an easy method called immunohistochemistry between cancers in patie...
Autores principales: | Rebuzzi, Sara Elena, Brunelli, Matteo, Galuppini, Francesca, Vellone, Valerio Gaetano, Signori, Alessio, Catalano, Fabio, Damassi, Alessandra, Gaggero, Gabriele, Rescigno, Pasquale, Maruzzo, Marco, Merler, Sara, Vignani, Francesca, Cavo, Alessia, Basso, Umberto, Milella, Michele, Panepinto, Olimpia, Mencoboni, Manlio, Sbaraglia, Marta, Dei Tos, Angelo Paolo, Murianni, Veronica, Cremante, Malvina, Llaja Obispo, Miguel Angel, Maffezzoli, Michele, Banna, Giuseppe Luigi, Buti, Sebastiano, Fornarini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136746/ https://www.ncbi.nlm.nih.gov/pubmed/37190322 http://dx.doi.org/10.3390/cancers15082394 |
Ejemplares similares
-
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022) -
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
por: Rescigno, Pasquale, et al.
Publicado: (2022) -
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022) -
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
por: Stellato, Marco, et al.
Publicado: (2021) -
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)